Ticker LaunchLondon · Main Market · Introduction · BNR
Burning Rock Biotech Limited
Burning Rock Biotech Limited (BNR) was admitted to Main Market on Nov 1, 2022 by way of introduction, without raising new money.
Burning Rock Biotech Limited applies next generation sequencing technology to precision oncology, with NGS-based therapy selection testing for late-stage cancer patients and cancer early detection.
- Type
- Introduction
- Market
- Main Market · Standard
- Ticker (TIDM)
- BNR
- Admitted
- Nov 1, 2022
- Sector
- Biotech & pharma
More on this listing for subscribers
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Ithaca Energy plcMain Market · Nov 14, 2022
- Bowen Fintech PLCMain Market · Oct 31, 2022
- Unicorn Mineral Resources plcMain Market · Oct 27, 2022
- Sondrel (Holdings) plcAIM · Oct 21, 2022
- ACG Acquisition Company LimitedMain Market · Oct 12, 2022
- Milton Capital plcMain Market · Oct 4, 2022